Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All brensocatib studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchBrensocatibBrensocatib (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   All Outcomes    Recent:   

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

Keir et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(22)00261-2, STOP-COVID19, ISRCTN30564012
Dec 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality -41% Improvement Relative Risk 7-point scale -39% primary Brensocatib  STOP-COVID19  LATE TREATMENT  DB RCT Is late treatment with brensocatib beneficial for COVID-19? Double-blind RCT 404 patients in the United Kingdom (Jun 2020 - Jan 2021) Higher mortality (p=0.019) and worse 7-point scale results (p=0.0072) c19early.org Keir et al., The Lancet Respiratory Me.., Dec 2022 Favorsbrensocatib Favorscontrol 0 0.5 1 1.5 2+
RCT 406 hospitalized COVID-19 patients in the UK showing higher mortality and worse clinical status with brensocatib (DPP-1 inhibitor) vs. placebo. Although blood neutrophil elastase activity was reduced, indicating the desired pharmacological effect, the results show worse clinical outcomes. Authors hypothesize that inhibiting DPP-1 and neutrophil serine proteases may have negatively impacted the delicate balance of neutrophils' protective and deleterious effects in the immune response to SARS-CoV-2.
risk of death, 41.0% higher, HR 1.41, p = 0.02, treatment 29 of 190 (15.3%), control 23 of 214 (10.7%), Cox proportional hazards, day 28.
risk of 7-point scale, 38.9% higher, OR 1.39, p = 0.007, treatment 190, control 214, adjusted per study, inverted to make OR<1 favor treatment, day 29, primary outcome, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Keir et al., 31 Dec 2022, Double Blind Randomized Controlled Trial, placebo-controlled, United Kingdom, peer-reviewed, 39 authors, study period 5 June, 2020 - 25 January, 2021, average treatment delay 8.5 days, trial ISRCTN30564012 (STOP-COVID19). Contact: jchalmers@dundee.ac.uk.
This PaperBrensocatibAll
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
PhD Holly R Keir, PhD Merete B Long, MD, Y H Giam BSc, T Pembridge BSc, L Delgado BSc, M Band MSc Hani Abo-Leyah, Yan Hui Giam, PhD Thenmalar Vadiveloo, Thomas Pembridge, Rebecca C Hull, Lilia Delgado, Margaret Band, Fiona Mclaren-Neil, PhD, E Lahnsteiner MSc, A Gilmour BSc Simon Adamson, Eva Lahnsteiner, Amy Gilmour, MSc Chloe Hughes, Benjamin Jm New, PhD, D David Connell, R C Hull BSc Rebecca Dowey, Helena Turton, PhD Hollian Richardson, Diane Cassidy, Jamie Cooper, MD Jay Suntharalingam, Lavanya Diwakar, PhD Peter Russell, PhD Jonathan Underwood, Davinder Alexander Hicks, Davinder Ps Dosanjh, Beth Sage, Devesh Dhasmana, PhD Mark Spears, Aa Roger Thompson, Christopher Brightling, Andrew Smith, Manish Patel, Prof Jacob George, Prof Alison M Condliffe, Amelia Shoemark, Prof Graeme Maclennan, on behalf of the STOP-COVID19 James D Chalmers, on behalf of the STOP-COVID19 James D Chalmers, MD, Y H Giam BSc, T Pembridge BSc, L Delgado BSc, M Band MSc Hani Abo-Leyah, Benjamin Jm New, Christine Almaden-Boyle, PhD, D David Connell, Jennifer Taylor, Jodie Strachan, Heather Loftus, Lesley Young, Angela Strachan, Margaret Band, Fiona Mclaren-Neil, Kristina Pilvinyte, PhD, E Lahnsteiner MSc, A Gilmour BSc Simon Adamson, Eva Lahnsteiner, Petra Rauchhaus, Fiona Hogarth, Prof Jacob George, Tricia Burns, Elizabeth Coote, Marney Keiller, Manish Patel, Andrew Smith, Elizabeth Sage, Jamie Cooper, David Miller, Davinder Dosanjh, Benjamin Sutton, PhD Jonathan Underwood, Sharon Frayling, Matthew Haynes, Lauren Broad, Laura Jones, Karen Rahilly, Catherine Oliver, Terriann Evans, Andrea Balan, Rhys Davies, Donal Forde, Clemency Nye, Dr Haboubi, Zoe Hilton, Jennie Williams, Alison Mcqueen, PhD Mark Spears, Ian Edmond, Dario Salutous, Laura Mcgenily, Rhona Scott, Eilidh Henderson, Andrea Collins, Devesh Dhasmana, Patrick Liu, Ana Morrow, Mandy Couser, Fleur Davey, Davinder Alexander Hicks, Laura Wiffen, Lauren Fox, Mohamed Abdelrahim, Alexander Darbyshire, Elena Cowen, Megan Rowley, Benjamin Giles, Yingjia Yang, Tom Brown, Hitasha Rupani, Elizabeth Hawes, Debi Barnes, Fiona Brogan, Roneleeh Bungue-Tuble, Serena Howe, Charlotte Turner, Sonia Baryschpolec, Bev Longhurst, Maria Moon, Lynn Watkins, Michelle Baker-Moffat, Lisa Murray, Yasmin Harrington-Davies, Kate Burrows, Chrissie Minnis, Mary Wands, Adefunke Bamgboye, Charlotte Wong, Christopher Brightling, Sarah Diver, Richard Russell, Hamish Mcauley, Omer Elneima, Ahmed Yousuf, Paula Mccourt, Beverley Hargadon, Sarah Parker, Michelle Bourne, MD Jay Suntharalingam, Tom Hartley, Vidan Masan, Sharon Sturney, Rob Mackenzie, Clare Marchand, Rebecca Mason, Katie White, Alison Kirby, Manjula Meda, Lavanya Diwakar, PhD Peter Russell, Joanne Finn, Sophie Harris, Carol Muir, Gemma Cook, Nikki Staines, Chris Cook, Aa Roger Thompson, Prof Alison M Condliffe, Rebecca C Hull, R C Hull BSc Rebecca Dowey, Helena Turton, Paul Collini, Zoé Gabriel, Simon Hardman, Helen Newell, Janet Middle, Phillip Simpson, Hayley Colton, Joann Barker, Katie Birchall, Kate Harrington, Kay Housley, Rebecca Lenagh, Jayne Wilson, Joan Wesonga, Rachel Whitham, Sarah Bird, Yvonne Jackson, Angeline Mbuyisa, Samantha Anderson, Anna Wilson, Faith Kibutu, Sara Walker, Kay Cawthron, Irene Macharia, Lynne Smart, Anna Emery, Alice Howell, Elizabeth Hurditch, Amber Ford, Kim Turner, Lisa Watson, Helen Bowler, Tracy Jackson, Carol Jaques, Nichole Dyer, Shelley Ducker, Vicky Goodall, Emily Udale
The Lancet Respiratory Medicine, doi:10.1016/s2213-2600(22)00261-2
Background Neutrophil serine proteases are involved in the pathogenesis of COVID-19 and increased serine protease activity has been reported in severe and fatal infection. We investigated whether brensocatib, an inhibitor of dipeptidyl peptidase-1 (DPP-1; an enzyme responsible for the activation of neutrophil serine proteases), would improve outcomes in patients hospitalised with COVID-19. Methods In a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial, across 14 hospitals in the UK, patients aged 16 years and older who were hospitalised with COVID-19 and had at least one risk factor for severe disease were randomly assigned 1:1, within 96 h of hospital admission, to once-daily brensocatib 25 mg or placebo orally for 28 days. Patients were randomly assigned via a central web-based randomisation system (TruST). Randomisation was stratified by site and age (65 years or ≥65 years), and within each stratum, blocks were of random sizes of two, four, or six patients. Participants in both groups continued to receive other therapies required to manage their condition. Participants, study staff, and investigators were masked to the study assignment. The primary outcome was the 7-point WHO ordinal scale for clinical status at day 29 after random assignment. The intention-totreat population included all patients who were randomly assigned and met the enrolment criteria. The safety population included all participants who received at least one dose of study medication. This study was registered with the ISRCTN registry, ISRCTN30564012. Findings Between June 5, 2020, and Jan 25, 2021, 406 patients were randomly assigned to brensocatib or placebo; 192 (47•3%) to the brensocatib group and 214 (52•7%) to the placebo group. Two participants were excluded after being randomly assigned in the brensocatib group (214 patients included in the placebo group and 190 included in the brensocatib group in the intention-to-treat population). Primary outcome data was unavailable for six patients (three in the brensocatib group and three in the placebo group). Patients in the brensocatib group had worse clinical status at day 29 after being randomly assigned than those in the placebo group (adjusted odds ratio 0•72 [95% CI 0•57-0•92]). Prespecified subgroup analyses of the primary outcome supported the primary results. 185 participants reported at least one adverse event; 99 (46%) in the placebo group and 86 (45%) in the brensocatib group. The most common adverse events were gastrointestinal disorders and infections. One death in the placebo group was judged as possibly related to study drug. Interpretation Brensocatib treatment did not improve clinical status at day 29 in patients hospitalised with COVID-19.
Declaration of interests JDC reports grants and personal fees from AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK, Gilead Sciences, Grifols, Insmed, Janssen, Novartis, and Zambon. CB reports grants from the UK National Institute for Health and Care Research Biomedical Research Centre during the conduct of the study; grants and personal fees from GSK, AstraZeneca, Chiesi, Boehringer-Ingelheim, Genentech, Roche, Sanofi, Regeneron, Merck, TEVA, Mologic, 4DPharma, and Novartis. AART reports grants and personal fees from British Heart Foundation and Actelion Pharmaceuticals. JU reports personal fees from Gilead Sciences and ViiV Healthcare and from Celltrion; and is supported by the UK Medical Research Council (MR/T023791/1). DPSD reports grants and personal fees from GSK, Vir Biotechnology, AstraZeneca, and Boehringer-Ingelheim. ASm has received non-financial support for clinical trial work from AstraZeneca, GSK, Chiesi, and Oncimmune; and has done consultancy work with AstraZeneca and GSK. MP reports non-financial support for clinical trial work from AstraZeneca, GSK, Chiesi, and Oncimmune and consultancy work with AstraZeneca and GSK. All other authors report no competing interests.
References
Ackermann, Anders, Bilyy, Patients with COVID-19: in the dark-NETs of neutrophils, Cell Death Differ
Acosta, Singer, Pathogenesis of COVID-19-induced ARDS: implications for an ageing population, Eur Respir J
Akk, Springer, Pham, Neutrophil extracellular traps enhance early inflammatory response in sendai virus-induced asthma phenotype, Front Immunol
Apel, Andreeva, Knackstedt, The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps, Sci Signal
Brown, Alazawi, Kanoni, Interleukin-6 receptor antagonists in critically ill patients with COVID-19, N Engl J Med
Chalmers, Crichton, Goeminne, Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline, Eur Respir J
Chalmers, Haworth, Metersky, Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis, N Engl J Med
Domon, Maekawa, Isono, Furuta, Kaito et al., Proteolytic cleavage of HLA class II by human neutrophil elastase in pneumococcal pneumonia, Sci Rep
Geerdink, Pillay, Meyaard, Bont, Neutrophils in respiratory syncytial virus infection: a target for asthma prevention, J Allergy Clin Immunol
Guan, Ni, Hu, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med
Horby, Lim, Emberson, Dexamethasone in hospitalized patients with COVID-19, N Engl J Med
Horby, Mafham, Linsell, Effect of hydroxychloroquine in hospitalized patients with COVID-19, N Engl J Med
Investigators, Gordon, Mouncey, Interleukin-6 receptor antagonists in critically ill patients with COVID-19-preliminary report, medRxiv, doi:10.1101/2021.01.07.21249390
Leisman, Ronner, Pinotti, Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes, Lancet Respir Med
Mcelvaney, Mcevoy, Mcelvaney, Characterization of the inflammatory response to severe COVID-19 illness, Am J Respir Crit Care Med
Palmér, Mäenpää, Jauhiainen, Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects, Clin Pharmacol Ther
Perng, Wu, Tsai, Neutrophil elastase stimulates human airway epithelial cells to produce PGE2 through activation of p44/42 MAPK and upregulation of cyclooxygenase-2, Am J Physiol Lung Cell Mol Physiol
Pham, Ley, Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo, Proc Natl Acad Sci
Porto, Stein, Neutrophil extracellular traps in pulmonary diseases: too much of a good thing?, Front Immunol
Schurink, Roos, Radonic, Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study, Lancet Microbe
Seren, Derian, Keleş, Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia, Eur Respir J
Sinha, Rosin, Arora, Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19, Nat Med
Stephenson, Reynolds, Botting, Single-cell multiomics analysis of the immune response in COVID-19, Nat Med
Tak, Rygiel, Karnam, Neutrophil-mediated suppression of influenza-induced pathology requires CD11b/CD18 (MAC-1), Am J Respir Cell Mol Biol
Tate, Deng, Jones, Anderson, Brooks et al., Neutrophils ameliorate lung injury and the development of severe disease during influenza infection, J Immunol
Turk, Janjić, Stern, Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases, EMBO J
Van Den Berg, Tambourgi, Clark, Hoong, Spiller et al., Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor, J Immunol
Veiga, Prats, Farias, Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial, BMJ
Veras, Pontelli, Silva, SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology, J Exp Med
Wolters, Pham, Muilenburg, Ley, Caughey, Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice, J Biol Chem
Zuo, Yalavarthi, Shi, Neutrophil extracellular traps in COVID-19, JCI Insight
{ 'indexed': {'date-parts': [[2024, 8, 20]], 'date-time': '2024-08-20T19:14:42Z', 'timestamp': 1724181282792}, 'reference-count': 32, 'publisher': 'Elsevier BV', 'issue': '12', 'license': [ { 'start': { 'date-parts': [[2022, 12, 1]], 'date-time': '2022-12-01T00:00:00Z', 'timestamp': 1669852800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2022, 7, 12]], 'date-time': '2022-07-12T00:00:00Z', 'timestamp': 1657584000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.com.au', 'clinicalkey.es', 'clinicalkey.com', 'thelancet.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 12]]}, 'DOI': '10.1016/s2213-2600(22)00261-2', 'type': 'journal-article', 'created': {'date-parts': [[2022, 9, 5]], 'date-time': '2022-09-05T12:16:17Z', 'timestamp': 1662380177000}, 'page': '1119-1128', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 8, 'title': 'Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, ' 'double-blind, randomised, parallel-group, placebo-controlled trial', 'prefix': '10.1016', 'volume': '10', 'author': [ {'given': 'Holly R', 'family': 'Keir', 'sequence': 'first', 'affiliation': []}, {'given': 'Merete B', 'family': 'Long', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hani', 'family': 'Abo-Leyah', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yan Hui', 'family': 'Giam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thenmalar', 'family': 'Vadiveloo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Pembridge', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca C', 'family': 'Hull', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lilia', 'family': 'Delgado', 'sequence': 'additional', 'affiliation': []}, {'given': 'Margaret', 'family': 'Band', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fiona', 'family': 'McLaren-Neil', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Adamson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Lahnsteiner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amy', 'family': 'Gilmour', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chloe', 'family': 'Hughes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin JM', 'family': 'New', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Connell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca', 'family': 'Dowey', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helena', 'family': 'Turton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hollian', 'family': 'Richardson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diane', 'family': 'Cassidy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jamie', 'family': 'Cooper', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jay', 'family': 'Suntharalingam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lavanya', 'family': 'Diwakar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter', 'family': 'Russell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Underwood', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander', 'family': 'Hicks', 'sequence': 'additional', 'affiliation': []}, {'given': 'Davinder PS', 'family': 'Dosanjh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Beth', 'family': 'Sage', 'sequence': 'additional', 'affiliation': []}, {'given': 'Devesh', 'family': 'Dhasmana', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mark', 'family': 'Spears', 'sequence': 'additional', 'affiliation': []}, {'given': 'AA Roger', 'family': 'Thompson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Brightling', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew', 'family': 'Smith', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manish', 'family': 'Patel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jacob', 'family': 'George', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alison M', 'family': 'Condliffe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amelia', 'family': 'Shoemark', 'sequence': 'additional', 'affiliation': []}, {'given': 'Graeme', 'family': 'MacLennan', 'sequence': 'additional', 'affiliation': []}, {'given': 'James D', 'family': 'Chalmers', 'sequence': 'additional', 'affiliation': []}, {'given': 'James', 'family': 'Chalmers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hani', 'family': 'Abo-Leyah', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin JM', 'family': 'New', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christine', 'family': 'Almaden-Boyle', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Connell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jennifer', 'family': 'Taylor', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jodie', 'family': 'Strachan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Heather', 'family': 'Loftus', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lesley', 'family': 'Young', 'sequence': 'additional', 'affiliation': []}, {'given': 'Angela', 'family': 'Strachan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Margaret', 'family': 'Band', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fiona', 'family': 'McLaren-Neil', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kristina', 'family': 'Pilvinyte', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Adamson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Lahnsteiner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Petra', 'family': 'Rauchhaus', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fiona', 'family': 'Hogarth', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jacob', 'family': 'George', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tricia', 'family': 'Burns', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elizabeth', 'family': 'Coote', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marney', 'family': 'Keiller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manish', 'family': 'Patel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew', 'family': 'Smith', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elizabeth', 'family': 'Sage', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jamie', 'family': 'Cooper', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Miller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Davinder', 'family': 'Dosanjh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin', 'family': 'Sutton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Underwood', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sharon', 'family': 'Frayling', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Haynes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lauren', 'family': 'Broad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Jones', 'sequence': 'additional', 'affiliation': []}, {'given': 'Karen', 'family': 'Rahilly', 'sequence': 'additional', 'affiliation': []}, {'given': 'Catherine', 'family': 'Oliver', 'sequence': 'additional', 'affiliation': []}, {'given': 'Terriann', 'family': 'Evans', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Balan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rhys', 'family': 'Davies', 'sequence': 'additional', 'affiliation': []}, {'given': 'Donal', 'family': 'Forde', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clemency', 'family': 'Nye', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dr', 'family': 'Haboubi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zoe', 'family': 'Hilton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jennie', 'family': 'Williams', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alison', 'family': 'McQueen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mark', 'family': 'Spears', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ian', 'family': 'Edmond', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dario', 'family': 'Salutous', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'McGenily', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rhona', 'family': 'Scott', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eilidh', 'family': 'Henderson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Collins', 'sequence': 'additional', 'affiliation': []}, {'given': 'Devesh', 'family': 'Dhasmana', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana', 'family': 'Morrow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mandy', 'family': 'Couser', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fleur', 'family': 'Davey', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander', 'family': 'Hicks', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Wiffen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lauren', 'family': 'Fox', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohamed', 'family': 'Abdelrahim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander', 'family': 'Darbyshire', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Cowen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Megan', 'family': 'Rowley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin', 'family': 'Giles', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yingjia', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tom', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hitasha', 'family': 'Rupani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elizabeth', 'family': 'Hawes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Debi', 'family': 'Barnes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fiona', 'family': 'Brogan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roneleeh', 'family': 'Bungue-Tuble', 'sequence': 'additional', 'affiliation': []}, {'given': 'Serena', 'family': 'Howe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charlotte', 'family': 'Turner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sonia', 'family': 'Baryschpolec', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bev', 'family': 'Longhurst', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Moon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lynn', 'family': 'Watkins', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michelle', 'family': 'Baker-Moffat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lisa', 'family': 'Murray', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yasmin', 'family': 'Harrington-Davies', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kate', 'family': 'Burrows', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chrissie', 'family': 'Minnis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mary', 'family': 'Wands', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adefunke', 'family': 'Bamgboye', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charlotte', 'family': 'Wong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Brightling', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sarah', 'family': 'Diver', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard', 'family': 'Russell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hamish', 'family': 'McAuley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Omer', 'family': 'Elneima', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ahmed', 'family': 'Yousuf', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paula', 'family': 'McCourt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Beverley', 'family': 'Hargadon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sarah', 'family': 'Parker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michelle', 'family': 'Bourne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jay', 'family': 'Suntharalingam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tom', 'family': 'Hartley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vidan', 'family': 'Masan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sharon', 'family': 'Sturney', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rob', 'family': 'MacKenzie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clare', 'family': 'Marchand', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca', 'family': 'Mason', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katie', 'family': 'White', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alison', 'family': 'Kirby', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manjula', 'family': 'Meda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lavanya', 'family': 'Diwakar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter', 'family': 'Russell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joanne', 'family': 'Finn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sophie', 'family': 'Harris', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carol', 'family': 'Muir', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gemma', 'family': 'Cook', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nikki', 'family': 'Staines', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chris', 'family': 'Cook', 'sequence': 'additional', 'affiliation': []}, {'given': 'AA Roger', 'family': 'Thompson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alison', 'family': 'Condliffe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca', 'family': 'Hull', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca', 'family': 'Dowey', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helena', 'family': 'Turton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Collini', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zoé', 'family': 'Gabriel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Hardman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helen', 'family': 'Newell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Janet', 'family': 'Middle', 'sequence': 'additional', 'affiliation': []}, {'given': 'Phillip', 'family': 'Simpson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hayley', 'family': 'Colton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joann', 'family': 'Barker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katie', 'family': 'Birchall', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kate', 'family': 'Harrington', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kay', 'family': 'Housley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca', 'family': 'Lenagh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jayne', 'family': 'Wilson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joan', 'family': 'Wesonga', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachel', 'family': 'Whitham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sarah', 'family': 'Bird', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yvonne', 'family': 'Jackson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Angeline', 'family': 'Mbuyisa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Samantha', 'family': 'Anderson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna', 'family': 'Wilson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Faith', 'family': 'Kibutu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sara', 'family': 'Walker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kay', 'family': 'Cawthron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Irene', 'family': 'Macharia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lynne', 'family': 'Smart', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna', 'family': 'Emery', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alice', 'family': 'Howell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elizabeth', 'family': 'Hurditch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amber', 'family': 'Ford', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kim', 'family': 'Turner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lisa', 'family': 'Watson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helen', 'family': 'Bowler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tracy', 'family': 'Jackson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carol', 'family': 'Jaques', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nichole', 'family': 'Dyer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shelley', 'family': 'Ducker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vicky', 'family': 'Goodall', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emily', 'family': 'Udale', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/S2213-2600(22)00261-2_bib1', 'doi-asserted-by': 'crossref', 'first-page': '1708', 'DOI': '10.1056/NEJMoa2002032', 'article-title': 'Clinical characteristics of coronavirus disease 2019 in China', 'volume': '382', 'author': 'Guan', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib2', 'doi-asserted-by': 'crossref', 'DOI': '10.1183/13993003.02049-2020', 'article-title': 'Pathogenesis of COVID-19-induced ARDS: implications for an ageing ' 'population', 'volume': '56', 'author': 'Torres Acosta', 'year': '2020', 'journal-title': 'Eur Respir J'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib3', 'doi-asserted-by': 'crossref', 'first-page': '1233', 'DOI': '10.1016/S2213-2600(20)30404-5', 'article-title': 'Cytokine elevation in severe and critical COVID-19: a rapid systematic ' 'review, meta-analysis, and comparison with other inflammatory syndromes', 'volume': '8', 'author': 'Leisman', 'year': '2020', 'journal-title': 'Lancet Respir Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib4', 'doi-asserted-by': 'crossref', 'first-page': '201', 'DOI': '10.1038/s41591-021-01576-3', 'article-title': 'Dexamethasone modulates immature neutrophils and interferon programming ' 'in severe COVID-19', 'volume': '28', 'author': 'Sinha', 'year': '2022', 'journal-title': 'Nat Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib5', 'doi-asserted-by': 'crossref', 'first-page': '3125', 'DOI': '10.1038/s41418-021-00805-z', 'article-title': 'Patients with COVID-19: in the dark-NETs of neutrophils', 'volume': '28', 'author': 'Ackermann', 'year': '2021', 'journal-title': 'Cell Death Differ'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib6', 'doi-asserted-by': 'crossref', 'first-page': 'e290', 'DOI': '10.1016/S2666-5247(20)30144-0', 'article-title': 'Viral presence and immunopathology in patients with lethal COVID-19: a ' 'prospective autopsy cohort study', 'volume': '1', 'author': 'Schurink', 'year': '2020', 'journal-title': 'Lancet Microbe'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib7', 'doi-asserted-by': 'crossref', 'DOI': '10.1183/13993003.03755-2020', 'article-title': 'Proteinase release from activated neutrophils in mechanically ' 'ventilated patients with non-COVID-19 and COVID-19 pneumonia', 'volume': '57', 'author': 'Seren', 'year': '2021', 'journal-title': 'Eur Respir J'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib8', 'doi-asserted-by': 'crossref', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'article-title': 'Dexamethasone in hospitalized patients with COVID-19', 'volume': '384', 'author': 'Horby', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib9', 'doi-asserted-by': 'crossref', 'first-page': '1147', 'DOI': '10.1056/NEJMc2108482', 'article-title': 'Interleukin-6 receptor antagonists in critically ill patients with ' 'COVID-19', 'volume': '385', 'author': 'Brown', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib10', 'doi-asserted-by': 'crossref', 'DOI': '10.1183/13993003.00048-2021', 'article-title': 'Management of hospitalised adults with coronavirus disease 2019 ' '(COVID-19): a European Respiratory Society living guideline', 'volume': '57', 'author': 'Chalmers', 'year': '2021', 'journal-title': 'Eur Respir J'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib11', 'doi-asserted-by': 'crossref', 'first-page': '1155', 'DOI': '10.1002/cpt.1053', 'article-title': 'Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, ' 'exposure-dependent reduction in neutrophil elastase activity in healthy ' 'subjects', 'volume': '104', 'author': 'Palmér', 'year': '2018', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib12', 'doi-asserted-by': 'crossref', 'first-page': '2127', 'DOI': '10.1056/NEJMoa2021713', 'article-title': 'Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis', 'volume': '383', 'author': 'Chalmers', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib13', 'doi-asserted-by': 'crossref', 'DOI': '10.1084/jem.20201129', 'article-title': 'SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 ' 'pathology', 'volume': '217', 'author': 'Veras', 'year': '2020', 'journal-title': 'J Exp Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib14', 'article-title': 'Neutrophil extracellular traps in COVID-19', 'volume': '5', 'author': 'Zuo', 'year': '2020', 'journal-title': 'JCI Insight'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib15', 'doi-asserted-by': 'crossref', 'first-page': '812', 'DOI': '10.1164/rccm.202005-1583OC', 'article-title': 'Characterization of the inflammatory response to severe COVID-19 ' 'illness', 'volume': '202', 'author': 'McElvaney', 'year': '2020', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib16', 'doi-asserted-by': 'crossref', 'first-page': '2030', 'DOI': '10.1056/NEJMoa2022926', 'article-title': 'Effect of hydroxychloroquine in hospitalized patients with COVID-19', 'volume': '383', 'author': 'Horby', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib17', 'doi-asserted-by': 'crossref', 'first-page': 'n84', 'DOI': '10.1136/bmj.n84', 'article-title': 'Effect of tocilizumab on clinical outcomes at 15 days in patients with ' 'severe or critical coronavirus disease 2019: randomised controlled ' 'trial', 'volume': '372', 'author': 'Veiga', 'year': '2021', 'journal-title': 'BMJ'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib18', 'doi-asserted-by': 'crossref', 'first-page': '1637', 'DOI': '10.1016/S0140-6736(21)00676-0', 'article-title': 'Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): ' 'a randomised, controlled, open-label, platform trial', 'volume': '397', 'year': '2021', 'journal-title': 'Lancet'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib19', 'article-title': 'Interleukin-6 receptor antagonists in critically ill patients with ' 'COVID-19—preliminary report', 'author': 'Gordon', 'year': '2021', 'journal-title': 'medRxiv'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib20', 'doi-asserted-by': 'crossref', 'first-page': '838', 'DOI': '10.1016/j.jaci.2015.06.034', 'article-title': 'Neutrophils in respiratory syncytial virus infection: a target for ' 'asthma prevention', 'volume': '136', 'author': 'Geerdink', 'year': '2015', 'journal-title': 'J Allergy Clin Immunol'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib21', 'doi-asserted-by': 'crossref', 'first-page': '325', 'DOI': '10.3389/fimmu.2016.00325', 'article-title': 'Neutrophil extracellular traps enhance early inflammatory response in ' 'sendai virus-induced asthma phenotype', 'volume': '7', 'author': 'Akk', 'year': '2016', 'journal-title': 'Front Immunol'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib22', 'doi-asserted-by': 'crossref', 'first-page': '311', 'DOI': '10.3389/fimmu.2016.00311', 'article-title': 'Neutrophil extracellular traps in pulmonary diseases: too much of a ' 'good thing?', 'volume': '7', 'author': 'Porto', 'year': '2016', 'journal-title': 'Front Immunol'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib23', 'doi-asserted-by': 'crossref', 'first-page': '492', 'DOI': '10.1165/rcmb.2017-0021OC', 'article-title': 'Neutrophil-mediated suppression of influenza-induced pathology requires ' 'CD11b/CD18 (MAC-1)', 'volume': '58', 'author': 'Tak', 'year': '2018', 'journal-title': 'Am J Respir Cell Mol Biol'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib24', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41598-021-82212-5', 'article-title': 'Proteolytic cleavage of HLA class II by human neutrophil elastase in ' 'pneumococcal pneumonia', 'volume': '11', 'author': 'Domon', 'year': '2021', 'journal-title': 'Sci Rep'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib25', 'doi-asserted-by': 'crossref', 'first-page': '1787', 'DOI': '10.4049/jimmunol.1301920', 'article-title': 'Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave ' 'and inactivate the C5a receptor', 'volume': '192', 'author': 'van den Berg', 'year': '2014', 'journal-title': 'J Immunol'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib26', 'doi-asserted-by': 'crossref', 'first-page': 'L925', 'DOI': '10.1152/ajplung.00182.2002', 'article-title': 'Neutrophil elastase stimulates human airway epithelial cells to produce ' 'PGE2 through activation of p44/42 MAPK and upregulation of ' 'cyclooxygenase-2', 'volume': '285', 'author': 'Perng', 'year': '2003', 'journal-title': 'Am J Physiol Lung Cell Mol Physiol'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib27', 'doi-asserted-by': 'crossref', 'DOI': '10.1126/scisignal.aax7942', 'article-title': 'The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps', 'volume': '14', 'author': 'Apel', 'year': '2021', 'journal-title': 'Sci Signal'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib28', 'doi-asserted-by': 'crossref', 'first-page': '904', 'DOI': '10.1038/s41591-021-01329-2', 'article-title': 'Single-cell multi-omics analysis of the immune response in COVID-19', 'volume': '27', 'author': 'Stephenson', 'year': '2021', 'journal-title': 'Nat Med'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib29', 'doi-asserted-by': 'crossref', 'first-page': '7441', 'DOI': '10.4049/jimmunol.0902497', 'article-title': 'Neutrophils ameliorate lung injury and the development of severe ' 'disease during influenza infection', 'volume': '183', 'author': 'Tate', 'year': '2009', 'journal-title': 'J Immunol'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib30', 'doi-asserted-by': 'crossref', 'first-page': '6570', 'DOI': '10.1093/emboj/20.23.6570', 'article-title': 'Structure of human dipeptidyl peptidase I (cathepsin C): exclusion ' 'domain added to an endopeptidase framework creates the machine for ' 'activation of granular serine proteases', 'volume': '20', 'author': 'Turk', 'year': '2001', 'journal-title': 'EMBO J'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib31', 'doi-asserted-by': 'crossref', 'first-page': '8627', 'DOI': '10.1073/pnas.96.15.8627', 'article-title': 'Dipeptidyl peptidase I is required for the processing and activation of ' 'granzymes A and B in vivo', 'volume': '96', 'author': 'Pham', 'year': '1999', 'journal-title': 'Proc Natl Acad Sci USA'}, { 'key': '10.1016/S2213-2600(22)00261-2_bib32', 'doi-asserted-by': 'crossref', 'first-page': '18551', 'DOI': '10.1074/jbc.M100223200', 'article-title': 'Dipeptidyl peptidase I is essential for activation of mast cell ' 'chymases, but not tryptases, in mice', 'volume': '276', 'author': 'Wolters', 'year': '2001', 'journal-title': 'J Biol Chem'}], 'container-title': 'The Lancet Respiratory Medicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2213260022002612?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S2213260022002612?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 1, 16]], 'date-time': '2023-01-16T14:41:19Z', 'timestamp': 1673880079000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2213260022002612'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 12]]}, 'references-count': 32, 'journal-issue': {'issue': '12', 'published-print': {'date-parts': [[2022, 12]]}}, 'alternative-id': ['S2213260022002612'], 'URL': 'http://dx.doi.org/10.1016/S2213-2600(22)00261-2', 'relation': {}, 'ISSN': ['2213-2600'], 'subject': [], 'container-title-short': 'The Lancet Respiratory Medicine', 'published': {'date-parts': [[2022, 12]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a ' 'multicentre, double-blind, randomised, parallel-group, placebo-controlled trial', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'The Lancet Respiratory Medicine', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/S2213-2600(22)00261-2', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, { 'value': 'https://doi.org/10.1016/S2213-2600(22)00293-4', 'name': 'associatedlink', 'label': 'CrossRef DOI link to the associated document'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2022 The Author(s). Published by Elsevier Ltd.', 'name': 'copyright', 'label': 'Copyright'}]}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit